Back to Results
First PageMeta Content



A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Niraparib Maintenance Treatment in Patients with HRD-Positive Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemothe
Add to Reading List

Document Date: 2016-07-01 14:54:26


Open Document

File Size: 356,72 KB

Share Result on Facebook